Car-T seems promising for leukemia and lymphoma, but not as efficacious in solid tumors: https://www.lls.org/treatment/types-treatment/immunotherapy/chimeric-a

Car-T seems promising for leukemia and lymphoma, but not as efficacious in solid tumors: https://www.lls.org/treatment/types-treatment/immunotherapy/chimeric-antigen-receptor-car-t-cell-therapy https://www.lls.org/treatment/types-treatment/immunotherapy/... Also 2nd gen BTK inhibitors: https://en.wikipedia.org/wiki/Acalabrutinib https://en.wikipedia.org/wiki/Acalabrutinib https://en.wikipedia.org/wiki/Bruton%27s_tyrosine_kinase https://en.wikipedia.org/wiki/Bruton%27s_tyrosine_kinase